What are the generic (ingredient) and chemical names for cisplatin, doxorubicin, and paclitaxel?
For these cancer drugs, “generic brand ingredient” usually refers to the active pharmaceutical ingredient (the ingredient name), while “chemical name” refers to the specific chemical description used on regulatory and labeling documents. The ingredient and chemical names below are the commonly used generic ingredient names and their corresponding chemical descriptions.
Cisplatin
The ingredient name is cisplatin. Its chemical name is cis-diamminedichloroplatinum(II).
Doxorubicin
The ingredient name is doxorubicin (often written as doxorubicin hydrochloride for the commonly marketed salt form). Its chemical name is doxorubicin.
Paclitaxel
The ingredient name is paclitaxel. Its chemical name is paclitaxel.
Why the “chemical name” may look identical to the ingredient name
For some drugs (notably paclitaxel and doxorubicin), regulatory chemical naming often uses the same term as the ingredient name because the ingredient name already encodes the full molecular identity used in official references. For cisplatin, the ingredient name is a shortened identifier of the more descriptive coordination complex name, so the chemical name differs (cis-diamminedichloroplatinum(II)).
Quick clarification: what you may mean by “generic brand ingredient”
If you mean “brand product that contains the drug,” tell me which brands (or which country/market), and I can map brand-to-ingredient for cisplatin, doxorubicin, and paclitaxel. If you instead need “generic drug substance chemical description exactly as on the label” (including salt forms like doxorubicin hydrochloride), specify the form (e.g., doxorubicin HCl, cisplatin injection, paclitaxel injection) and I’ll align the names accordingly.